1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Vakonakis, I. Campbell, I.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Embo J. EMJODG 0897 0261-4189 26 2575 2583 10.1038/sj.emboj.7601694 17464288 Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis. 2007 10.2210/pdb2h41/pdb pdb_00002h41 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 10202.056 Fibronectin Fibronectin type-III 2(2F3) 1 man polymer FN, Cold-insoluble globulin, CIG no no GPLGSHLVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQIS EDGEQSLILSTSQTT GPLGSHLVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQIS EDGEQSLILSTSQTT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample FN1 9606 Homo sapiens 562 Escherichia coli BL21(DE3)-RP plasmid pGEX-6P-2 database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2007-04-10 1 1 2008-05-01 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details 1H, 13C and 15N chemical shift assignments 25 models for the same protein HELIX (no helix) DETERMINATION METHOD: AUTHOR DETERMINED RCSB Y PDBJ 2006-05-23 REL REL 1 3D_15N-separated_NOESY HNHA 4D_13C-separated_NOESY HNHB 15N IPAP-HSQC C-C long range couplings Methyl - carbonyl couplings Methyl - nitrogen couplings HACAHB 20mM NaCl, 20mM Na2HPO4 7.0 ambient 303 K Structure based on 2827 restraints Simulated annealing in cartesian space minimized average structure 2.5mM 2F3 U-15N, 20mM NaPi pH 7.0, 20mM NaCl, 95% H2O, 5% D2O 95% H2O/5% D2O 2mM 2F3 U-13C,15N, 20mM NaPi pH 7.0, 20mM NaCl, 95% H2O, 5% D2O 95% H2O/5% D2O 2mM 2F3 U-13C,15N, 20mM NaPi pH 7.0, 20mM NaCl, 100% D2O 100% D2O 1mM 2F3 U-15N, 20mM NaPi pH 7.0, 20mM NaCl, 4% Radially compressed polyacrylamide gel, 95% H2O, 5% D2O 95% H2O/5% D2O GE/Bruker collection Omega Beta 6.0.3b2 Frank Delaglio, NIH/NIDDK/LCP processing NMRPipe 2.3 Rev 2005.319.11.22 Dan Garrett, NIH/NIDDK/LCP data analysis PIPP 4.3.7 Schwieters, Kuszewski, Tjandra, Clore, NIH/NIDDK/LCP structure solution XPLOR-NIH 2.12 Schwieters, Kuszewski, Tjandra, Clore, NIH/NIDDK/LCP refinement XPLOR-NIH 2.12 500 Home-built Home built 600 Home-built Home built GLY 1 n 1 GLY 1 A PRO 2 n 2 PRO 2 A LEU 3 n 3 LEU 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A HIS 6 n 6 HIS 6 A LEU 7 n 7 LEU 7 A VAL 8 n 8 VAL 8 A ALA 9 n 9 ALA 9 A THR 10 n 10 THR 10 A SER 11 n 11 SER 11 A GLU 12 n 12 GLU 12 A SER 13 n 13 SER 13 A VAL 14 n 14 VAL 14 A THR 15 n 15 THR 15 A GLU 16 n 16 GLU 16 A ILE 17 n 17 ILE 17 A THR 18 n 18 THR 18 A ALA 19 n 19 ALA 19 A SER 20 n 20 SER 20 A SER 21 n 21 SER 21 A PHE 22 n 22 PHE 22 A VAL 23 n 23 VAL 23 A VAL 24 n 24 VAL 24 A SER 25 n 25 SER 25 A TRP 26 n 26 TRP 26 A VAL 27 n 27 VAL 27 A SER 28 n 28 SER 28 A ALA 29 n 29 ALA 29 A SER 30 n 30 SER 30 A ASP 31 n 31 ASP 31 A THR 32 n 32 THR 32 A VAL 33 n 33 VAL 33 A SER 34 n 34 SER 34 A GLY 35 n 35 GLY 35 A PHE 36 n 36 PHE 36 A ARG 37 n 37 ARG 37 A VAL 38 n 38 VAL 38 A GLU 39 n 39 GLU 39 A TYR 40 n 40 TYR 40 A GLU 41 n 41 GLU 41 A LEU 42 n 42 LEU 42 A SER 43 n 43 SER 43 A GLU 44 n 44 GLU 44 A GLU 45 n 45 GLU 45 A GLY 46 n 46 GLY 46 A ASP 47 n 47 ASP 47 A GLU 48 n 48 GLU 48 A PRO 49 n 49 PRO 49 A GLN 50 n 50 GLN 50 A TYR 51 n 51 TYR 51 A LEU 52 n 52 LEU 52 A ASP 53 n 53 ASP 53 A LEU 54 n 54 LEU 54 A PRO 55 n 55 PRO 55 A SER 56 n 56 SER 56 A THR 57 n 57 THR 57 A ALA 58 n 58 ALA 58 A THR 59 n 59 THR 59 A SER 60 n 60 SER 60 A VAL 61 n 61 VAL 61 A ASN 62 n 62 ASN 62 A ILE 63 n 63 ILE 63 A PRO 64 n 64 PRO 64 A ASP 65 n 65 ASP 65 A LEU 66 n 66 LEU 66 A LEU 67 n 67 LEU 67 A PRO 68 n 68 PRO 68 A GLY 69 n 69 GLY 69 A ARG 70 n 70 ARG 70 A LYS 71 n 71 LYS 71 A TYR 72 n 72 TYR 72 A ILE 73 n 73 ILE 73 A VAL 74 n 74 VAL 74 A ASN 75 n 75 ASN 75 A VAL 76 n 76 VAL 76 A TYR 77 n 77 TYR 77 A GLN 78 n 78 GLN 78 A ILE 79 n 79 ILE 79 A SER 80 n 80 SER 80 A GLU 81 n 81 GLU 81 A ASP 82 n 82 ASP 82 A GLY 83 n 83 GLY 83 A GLU 84 n 84 GLU 84 A GLN 85 n 85 GLN 85 A SER 86 n 86 SER 86 A LEU 87 n 87 LEU 87 A ILE 88 n 88 ILE 88 A LEU 89 n 89 LEU 89 A SER 90 n 90 SER 90 A THR 91 n 91 THR 91 A SER 92 n 92 SER 92 A GLN 93 n 93 GLN 93 A THR 94 n 94 THR 94 A THR 95 n 95 THR 95 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N PHE 22 A N PHE 22 A O ILE 63 A O ILE 63 A O LEU 54 A O LEU 54 A N PHE 36 A N PHE 36 A N SER 34 A N SER 34 A O ILE 79 A O ILE 79 A N VAL 76 A N VAL 76 A O LEU 89 A O LEU 89 1 A A HD12 ND1 LEU HIS 3 6 0.50 1 A A CD1 ND1 LEU HIS 3 6 0.80 1 A A O H SER SER 28 30 0.84 1 A A HG H SER LEU 5 7 0.89 1 A A OE1 HH21 GLU ARG 45 70 0.89 1 A A CD1 HD1 LEU HIS 3 6 0.97 1 A A C H HIS VAL 6 8 0.99 1 A A O H GLU VAL 12 14 1.00 1 A A O H HIS VAL 6 8 1.04 1 A A HD13 HD1 LEU HIS 3 6 1.04 1 A A HD12 CG LEU HIS 3 6 1.05 1 A A HD12 HD1 LEU HIS 3 6 1.08 1 A A HG NE2 LEU HIS 3 6 1.08 1 A A CD HH21 GLU ARG 45 70 1.09 1 A A HG CE1 LEU HIS 3 6 1.10 1 A A O HG21 ALA THR 9 10 1.14 1 A A O H PRO SER 2 5 1.15 1 A A OD1 H ASP GLU 47 48 1.15 1 A A C H GLU VAL 12 14 1.27 1 A A O N HIS VAL 6 8 1.28 1 A A O H VAL ALA 27 29 1.33 1 A A O N GLU VAL 12 14 1.33 1 A A H O SER ILE 34 79 1.35 1 A A HD13 ND1 LEU HIS 3 6 1.37 1 A A O HG13 THR ILE 15 17 1.43 1 A A O HB3 GLY SER 4 5 1.44 1 A A O H LEU ALA 7 9 1.46 1 A A HG OD1 SER ASP 80 82 1.46 1 A A O H PRO GLY 2 4 1.49 1 A A H O PHE LEU 36 54 1.53 1 A A C HE2 PRO HIS 2 6 1.53 1 A A CG CE1 LEU HIS 3 6 1.53 1 A A HB2 CD2 LEU HIS 3 6 1.54 1 A A O HD21 PHE ASN 22 62 1.54 1 A A C H PRO GLY 2 4 1.59 1 A A CG2 H THR SER 10 11 1.60 1 A A O H THR ILE 15 17 1.60 1 A A O N PRO GLY 2 4 1.60 1 A A OD1 OE1 ASP GLU 47 48 1.61 1 A A CD1 CE1 LEU HIS 3 6 1.63 1 A A OD1 CD ASP GLU 47 48 1.65 1 A A O OG GLU SER 16 21 1.67 1 A A O O GLY ASP 46 47 1.69 1 A A O N LEU ALA 7 9 1.70 1 A A O N SER SER 28 30 1.77 1 A A O CG2 ALA THR 9 10 1.79 1 A A OG OD1 SER ASP 80 82 1.80 1 A A OE1 NH2 GLU ARG 45 70 1.82 1 A A OE2 NH2 GLU ARG 45 70 1.83 1 A A C N HIS VAL 6 8 1.84 1 A A CG ND1 LEU HIS 3 6 1.85 1 A A CD1 CG LEU HIS 3 6 1.86 1 A A CG NE2 LEU HIS 3 6 1.90 1 A A CD NH2 GLU ARG 45 70 1.92 1 A A O N THR ILE 15 17 1.99 1 A A O N PRO SER 2 5 2.03 1 A A C N GLU VAL 12 14 2.06 1 A A CB CD2 LEU HIS 3 6 2.14 1 A A O CA HIS VAL 6 8 2.15 1 A A C N PRO GLY 2 4 2.19 1 A LEU 3 21.40 19.17 1 A SER 5 116.28 -37.19 1 A HIS 6 56.86 15.67 1 A LEU 7 29.80 -3.21 1 A VAL 8 12.30 -49.29 1 A ALA 9 -26.42 -80.38 1 A THR 10 102.52 -108.06 1 A SER 11 -37.91 113.97 1 A GLU 12 -9.35 72.96 1 A SER 13 -18.93 -7.54 1 A THR 15 -93.39 -76.62 1 A GLU 16 -35.83 69.23 1 A ALA 19 54.11 16.81 1 A SER 28 -57.88 58.24 1 A ALA 29 -38.07 24.48 1 A SER 30 179.22 128.80 1 A GLU 44 -109.87 -69.65 1 A ASP 47 -27.99 -171.71 minimized average Solution structure of the second type III domain of human Fibronectin: minimized average structure 1 N N A PRO 2 A PRO 2 HELX_P A HIS 6 A HIS 6 5 1 5 A ILE 17 A ILE 17 HELX_P A SER 21 A SER 21 5 2 5 CELL ADHESION, STRUCTURAL PROTEIN beta sandwich, CELL ADHESION, STRUCTURAL PROTEIN FINC_HUMAN UNP 1 721 P02751 LVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQISEDGEQS LILSTSQTT 721 809 2H41 7 95 P02751 A 1 7 95 1 cloning artifact GLY 1 2H41 A P02751 UNP 1 1 cloning artifact PRO 2 2H41 A P02751 UNP 2 1 cloning artifact LEU 3 2H41 A P02751 UNP 3 1 cloning artifact GLY 4 2H41 A P02751 UNP 4 1 cloning artifact SER 5 2H41 A P02751 UNP 5 1 cloning artifact HIS 6 2H41 A P02751 UNP 6 2 4 anti-parallel anti-parallel anti-parallel anti-parallel A PHE 22 A PHE 22 A SER 25 A SER 25 A SER 60 A SER 60 A ILE 63 A ILE 63 A GLN 50 A GLN 50 A PRO 55 A PRO 55 A VAL 33 A VAL 33 A LEU 42 A LEU 42 A LYS 71 A LYS 71 A SER 80 A SER 80 A GLN 85 A GLN 85 A THR 94 A THR 94